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ABSTRACT
Atherosclerosis is an inflammatory disease in which an accumulation of fatty
acids and cholesterol occurs to form a plaque in small and large arteries. Monocyte
polarization to classic M1 macrophages or alternative M2 macrophages is an important
area of research that can determine the severity of disease progression. BMP-7 is a key
growth factor responsible for directing differentiation of mesenchymal stem cells into
brown fat cells, suggesting a role of BMP-7 in cellular plasticity; however, its role in
monocyte polarization is yet to be revealed. In the current study, we hypothesize that
monocyte treatment with BMP-7 will significantly result in increased polarization of
monocytes into M2 macrophages and increased expression of anti-inflammatory
cytokines. To that effect, we have established a stress induced cell culture system with
monocytes (THP-1 cells) and apoptotic conditioned medium (ACM), simulating injury, to
understand the effects of BMP-7 on M2 macrophage polarization from monocytes. Our
data demonstrates that the BMP type 2 receptor (BMPR2) is found on monocytes and
its activation is significantly (p<0.05) increased in both monocytes and M2 macrophages
following treatment with BMP-7. Furthermore, a significant (p<0.05) increase of M2
macrophages in the BMP-7 treated group was shown following immunostaining with
CD206 and arginase-1, two M2 macrophage markers, whereas a significant (p<0.05)
decrease of iNOS expression, an M1 macrophage marker, was shown.

Moreover,

treatment with BMP-7 resulted in significantly (p<0.05) increased expression of IL-10
and IL-1ra, two anti-inflammatory cytokines, but significantly (p<0.05) decreased levels
of the pro-inflammatory cytokines, MCP-1, IL-6 and TNF-α. We also hypothesize that
polarization of monocytes to M2 macrophages occurs through activation of SMAD1/5/8
iii

and PI3K-Akt-mTOR pathways. Upon BMP-7 binding to its receptor, BMPR2, activation
of SMAD1/5/8 occurs which then activates the p85 subunit of PI3K resulting in
downstream activation of Akt and mTOR. Our data shows that following treatment with
BMP-7, expression of p-SMAD1/5/8, p-PI3K, p-Akt and p-mTOR is significantly (p<0.05)
increased compared to controls whereas p-PTEN, an inhibitor of the PI3K pathway, is
significantly (p<0.05) decreased in the BMP-7 treated group compared to controls. In
conclusion, our data reveals that BMP-7 polarizes monocytes into M2 macrophages and
it achieves this through activation of the PI3K-Akt-mTOR pathway, which will have
significant applications for atherosclerosis treatment.
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CHAPTER 1: INTRODUCTION
Atherosclerosis and Inflammation
Atherosclerosis is a disease which results in the accumulation of fat and
cholesterol in large and small arteries (Seimon and Tabas, 2009;Moore and Tabas,
2011;Shimizu et al., 2012). This plaque formation that occurs causes hardening and
narrowing of the arteries which can lead to further complications such as a myocardial
infarction or an ischemic stroke (Libby et al., 2009;Rocher et al., 2012).

Recently

studies have focused on the inflammatory response that occurs with atherosclerosis
and refer to this condition as an inflammatory disease (Libby et al., 2009).

In

atherosclerosis, monocytes migrate to the area of injury and polarize based on the
environment and the factors being secreted (Seimon and Tabas, 2009). In early stages
of atherosclerosis, polarization of M2 macrophages is greater and allows for secretion of
anti-inflammatory cytokines and efferocytosis to occur but in later stages of
atherosclerosis, the injury becomes too great and cellular debris becomes necrotic
causing a pro-inflammatory environment and M1 polarization from monocytes to occur
(Thorp and Tabas, 2009;Libby et al., 2009;Seimon and Tabas, 2009;Moore and Tabas,
2011).

Monocyte Polarization
Monocyte polarization involving classical M1 macrophages and alternative M2
macrophages is an emerging area of research that plays a significant role in various
conditions and diseases (Xu et al., 2006;Weis et al., 2009;Rocher et al., 2012).
Classical M1 macrophages are known to be pro-inflammatory and secrete such
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cytokines as iNOS, IL-6, TNF-α, and MCP-1, while alternative M2 macrophages are
anti-inflammatory and secrete such cytokines as IL-10 and arginase-1 (Sinha et al.,
2005;Xu et al., 2006;Weis et al., 2009;Rocher et al., 2012). Therefore, having a greater
ratio of M2 macrophages is essential for injury repair and wound healing. Monocyte
polarization is also influenced by the stimuli received from the external environment
based on their ability to exhibit high plasticity (Woollard and Geissmann, 2010;Rocher et
al., 2012).

Bone Morphogenetic Protein-7 and SMAD1/5/8 Pathway
Bone morphogenetic protein-7 (BMP-7), which is part of the TGFβ family, is
essential for the embryonic development of the eyes, kidneys and skeleton, is shown to
be involved in cell polarization and demonstrated to reduce expression of such proinflammatory cytokines as IL-6 and MCP-1 in the kidney (Wang et al., 2003;Boon et al.,
2011;Rocher et al., 2012). Furthermore, we recently published the effect of BMP-7
treatment on THP-1 cells as well as the effects of its inhibitor, follistatin (Rocher et al.,
2012).

We showed that BMP-7 treatment was able to successfully increase anti-

inflammatory cytokine expression such as IL-10 and induce increased polarization of
monocytes to M2 macrophages (Rocher et al., 2012). BMP-7 works through the
SMAD1/5/8 pathway following binding to the BMP type 2 receptor (BMPR2) on the
surface of the cell (Boon et al., 2011). Follistatin works to inhibit BMP-7 by preventing
the binding of BMP-7 with BMPR2 and thus preventing the activation of the SMAD1/5/8
pathway (Amthor et al., 2002;Rocher et al., 2012). Binding of BMP-7 with its receptor,
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however, has also been shown to activate other non-SMAD pathways such as the PI3KAkt-mTor pathway (Shimizu et al., 2012).

PI3K-Akt-mTOR Pathway
The PI3K pathway has been shown to be essential to immune regulation and
induces a more anti-inflammatory environment (Weichhart and Saemann, 2008).
Studies have reported that this pathway inhibits the release of pro-inflammatory
cytokines and its activation is required for M2 macrophage polarization (Rauh et al.,
2005;Weichhart and Saemann, 2008;Weichhart and Saemann, 2009). This pathway,
works through the activation and phosphorylation of the p85 subunit of PI3K which
results in downstream phosphorylation of PIP2 to PIP3 (Weichhart and Saemann,
2008).

This results in phosphorylation of Akt and downstream activation of mTOR

(Weichhart and Saemann, 2008).

PTEN, an inhibitor of this pathway, works by

dephosphorylating PIP3 and thus preventing activation of Akt (Weichhart and Saemann,
2008). In this study we will show that following treatment of BMP-7, THP-1 cells will
polarize into M2 macrophages.

Furthermore, we will show that activation of the

SMAD1/5/8 pathway will activate the p85 subunit of PI3K resulting in activation of the
PI3K-Akt-mTOR pathway.

Hypothesis
In the present study, we hypothesize that:
I.

Monocyte treatment with BMP-7 under stressed conditions will greatly increase
polarization of monocytes into M2 macrophages and increase expression of antiinflammatory cytokines.
3

II.

Polarization by BMP-7 is mediated through both the SMAD1/5/8 and PI3K-AktmTOR pathways.

Aims
Aim 1. Determine whether under stressed conditions, BMP-7 can induce M2
macrophage polarization from THP-1 cells and primary CD14 monocytes after 48 hours
of treatment.
Aim 2. Determine the mechanism involved in the observed M2 macrophage
polarization.
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CHAPTER 2: MATERIALS AND METHODS
THP-1 Cell Culture
THP-1 cells are a cell line for human monocytes that were used in this study and
purchased from ATCC. The monocytes were cultured with RPMI 1640 (ATCC) which
contained 10% fetal bovine serum and 0.05mM β-mercaptoethanol. THP-1 cells were
grown in suspension in 25cm2 flasks and media was added every other day as per
manufacturer’s instructions (Rocher et al., 2012).

Apoptotic Conditioned Media
The H9C2 cell line was used to generate apoptotic condition media which is an
established method and has been published by us (Singla and McDonald, 2007;Rocher
et al., 2012). A 60mm tissue culture plate was plated with 5x105 H9C2 cells for 24
hours. Following 24 hours, 400uM of H2O2 was added to the plate for 2 hours. After 2
hours, the media was removed from the plate and filtered.

BMP-7 and Follistatin Treatment
A total of 40,000 THP-1 cells were plated per well in a 24 well plate for 24 hours.
The cells were split up into the following groups: Control, ACM, ACM+BMP-7 and
ACM+BMP-7+Foll. Following 24 hours, cells were treated according to the designated
groups for 48 hours. Cells treated with BMP-7 were given a concentration of 660ng/ml
and cells treated with follistatin were given a concentration of 500ng/ml (Rocher et al.,
2012).
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Double Label Immunostaining of BMPR2 with CD14 and CD206
As previously reported, after 48 hours of treatment, cells were removed from the
wells and centrifuged for 5 minutes at 300g (Rocher et al., 2012).

Following

centrifugation, cell smears were made using ColorFrost Plus glass slides and allowed to
dry. When smears were ready blocking was done with 10% normal goat serum (Vector
Labs) for one hour at room temperature. Primary antibodies for anti-CD14 or antiCD206 were added and incubated for 24 hours. Smears were then left in secondary
antibody goat anti-rabbit Alexa 568 for one hour. Next smears were blocked with 10%
donkey serum and then primary antibody anti-BMPR2 was added for 24 hours.
Secondary antibody donkey anti-goat Alexa 488 was then added. Smears were then
counter stained to visualize all blue nuclei with DAPI (4’, 6-diamidino-2-phenylindole)
(Vector Labs) and the slides were cover-slipped. Four images per smear were taken
and analyzed.

Immunohistochemistry of Macrophage Markers Arginase-1 and iNOS
First, smears were blocked with 10% normal goat serum (Vector Labs). Next,
anti-iNOS was added and kept for 24 hours.

Goat anti-mouse Alexa 568, the

secondary, was then added. Next, smears were blocked with 10% donkey serum and
then anti-arginase-1 was added also for 24 hours. Smears were next given secondary
antibody donkey anti-goat Alexa 488. Smears were then counter stained to visualize all
blue nuclei with DAPI (4’, 6-diamidino-2-phenylindole) (Vector Labs) and the slides were
cover-slipped. Four images per smear were taken and analyzed.

6

Pro and Anti-Inflammatory Cytokine ELISAs
Supernatant from each group was collected after 48 hours of treatment and
centrifuged at 13,000 rpm for 5 minutes as previously reported (Rocher et al., 2012). In
brief, pro (IL-6, TNF-α, and MCP-1) and anti-inflammatory (IL-10) ELISA kits were
purchased from Raybiotech and followed under manufacturer’s instructions.

Western Blot Analysis
Cells were divided and plated in 25cm2 flasks per group. Following 48 hours of
treatment, cells were collected, centrifuged and lysed with RIPA buffer containing
protease inhibitor cocktail, PMSF, sodium orthovanadate and sodium fluoride for 30
minutes. The cell lysates were then used to measure the protein concentration and
following, protein concentration determination, samples were made from the cell lysates
and were run on either an 8% or 10% sodium-dodecyl sulfate polyacrylamide gel at
100V for 5 minutes and then 150V for 55 minutes. Next the gels were transferred onto
a PVDF membrane (Bio-Rad).

After transferring the gels onto the membrane, the

membranes were blocked with 5% milk and primary antibodies p-Smad 1/5/8, p-PI3K,
Total PI3K, p-Akt, p-PTEN, p-mTOR or Total mTOR were added followed by secondary
antibody. Finally the membranes were detected with a Visualizer.

Statistical Analysis
Statistical analysis was done using one-way analysis of variance (ANOVA) then
Tukey Test. Data are given as a mean ± SEM with p-value <0.05 to show statistical
significance.
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CHAPTER 3: RESULTS
BMPR2 Expression is Increased Following BMP-7 Treatment
To confirm the presence of BMPR2 on THP-1 cells, a double immunostaining
was performed.

Figure 1A shows representative photomicrographs of THP-1 cells

stained with CD14, a monocyte marker, and BMPR2.

Furthermore, quantitative

analysis shows that expression of BMPR2 is significantly increased in the ACM+BMP-7
group following treatment with BMP-7 compared to control (Figure 1C).

A double

immunostaining with CD206, an M2 macrophage marker, and BMPR2 further
demonstrates that the receptor is located on M2 macrophages as well and expression
of the receptor is significantly increased in the ACM+BMP-7 group following treatment
with BMP-7 compared to the control (Figure 1B and D).
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Figure 1: Expression of BMPR2 is increased following treatment with BMP-7. Top
panel (A) shows representative photomicrographs of cell smears stained with antiBMPR2 in green (a), anti-CD14, a monocyte marker, in red (b), DAPI in blue (c) and the
merged image (d). Bottom panel (B) shows representative photomicrographs of antiBMPR2 in green (e), anti-CD206, an M2 macrophage marker, in red (f), DAPI in blue (g)
and the merged image (h). Bottom left histogram (C) shows quantitative analysis of
percent BMPR2 positive CD14 cells. Right histogram (D) shows quantitative analysis of
percent BMPR2 positive CD206 cells. *p<0.05 vs Control.

9

BMP-7 Treatment Increases M2 Macrophage Polarization
Polarization of THP-1 cells following treatment with BMP-7 was next determined
by immunohistochemistry.

Figure 2A shows quantitative analysis of CD14

immunostaining showing a significant decrease of CD14 positive cells in the ACM,
ACM+BMP-7 and ACM+BMP-7+Foll groups. This suggests that the cells are polarizing
into another cell type following treatment. To determine what the cells are polarizing
into, THP-1 cells were stained with CD206 and arginase-1, two M2 macrophage marker,
and iNOS, an M1 macrophage marker (Sinha et al., 2005;Xu et al., 2006;Weichhart and
Saemann, 2008). Figure 2B shows quantitative analysis of CD206 positive cells with a
significant increase in the ACM+BMP-7 group and a significant decrease in the
ACM+BMP-7+Follistatin group suggesting that BMP-7 treatment successfully polarizes
THP-1 cells into M2 macrophages and follistatin, an inhibitor of BMP-7, prevents the
polarization from occurring (Boon et al., 2011). Next, Figure 2C shows quantitative
analysis of arginase-1 positive cells with a significant increase in the ACM+BMP-7
group which further suggests that BMP-7 is successfully polarizing the THP-1 cells into
M2 macrophages. Lastly, Figure 2D shows quantitative analysis of iNOS positive cells
with a significant increase in the ACM and ACM+BMP-7+Foll groups and a significant
decrease in the ACM+BMP-7 group. This suggests that without treatment of BMP-7
cells polarize into an M1 macrophage-expressing cell.
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Figure 2: Treatment with BMP-7 increases M2 macrophage markers while decreasing
M1 markers. Top left histogram (A) shows quantitative analysis of percent CD14
positive cells. Top right histogram (B) shows quantitative analysis of percent CD206
positive cells. Bottom left histogram (C) shows quantitative analysis of percent
arginase-1 positive cells. Bottom right histogram (D) shows quantitative analysis of
percent iNOS positive cells. *p<0.05 vs Control, #p<0.05 vs ACM, $p<0.05 vs
ACM+BMP-7.
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Expression of Inflammatory Cytokines Following Treatment with BMP-7
Another method of determining M1 and M2 macrophage polarization is by
expression of pro and anti-inflammatory cytokines (El et al., 2012;Rocher et al., 2012).
ELISA kits were used to measure the levels of cytokines per group. IL-10, an antiinflammatory cytokine and marker of M2 macrophages, was measured and
demonstrated a significant increase in the ACM+BMP-7 group and a significant
decrease in the ACM and ACM+BMP-7+Foll group (Figure 3A).

Figure 3B shows

expression of IL-1ra, another anti-inflammatory cytokine, with also a significant increase
in the ACM+BMP-7 group. IL-6, TNF- α and MCP-1 are pro-inflammatory cytokines that
are known to be expressed by M1 macrophages and contribute to the progression of
inflammatory diseases, were also measured (Weis et al., 2009;Rocher et al., 2012).
Figures 3C-D show quantitative analysis of expression of the pro-inflammatory
cytokines with a significant decrease in the ACM+BMP-7 group suggesting that
treatment with BMP-7 inhibits expression of these cytokines.
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Figure 3: BMP-7 increases anti-inflammatory cytokine expression and decreases proinflammatory cytokine expression. Histogram (A) shows quantitative analysis of IL-10.
Histogram (B) shows quantitative analysis of IL-1ra. Histogram (C) shows quantitative
analysis of IL-6. Histogram (D) shows quantitative analysis of TNF- α. Histogram (E)
shows quantitative analysis of MCP-1. *p<0.05 vs Control, #p<0.05 vs ACM, $p<0.05
vs ACM+BMP-7.
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BMP-7 Treatment Activates the SMAD1/5/8 Pathway
When BMP-7 binds to BMPR2 located on the THP-1 cells, the SMAD1/5/8
pathway gets activated which results in gene expression (Perron and Dodd, 2009;Boon
et al., 2011).

Western blot analysis was utilized to ascertain the expression of

SMAD1/5/8 per group.

Figure 4A shows representative western blot bands for

SMAD1/5/8 and β-actin. Densitometry analysis of the western blot bands showed that
expression of SMAD1/5/8 was significantly higher in the ACM+BMP-7 group suggesting
that BMP-7 is successfully binding the receptor and further confirming that the receptor
is active on THP-1 cells. (Figure 4B).
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Figure 4: Treatment with BMP-7 increases activation of SMAD1/5/8 pathway.
Representative western blot bands (A) are shown of p-SMAD1/5/8 and β-actin.
Histogram (B) shows analysis of p-SMAD1/5/8. *p<0.05 vs Control, #p<0.05 vs ACM,
$p<0.05 vs ACM+BMP-7.
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Binding of BMPR2 Activates Non-SMAD Pathway PI3K-Akt-mTOR
Studies have shown that activation of the BMPR2 can also result in activation of
non-SMAD related pathways such as the PI3K pathway (Shimizu et al., 2012). When
binding occurs, the p85 subunit of PI3K gets activated which allows for downstream
activation of Akt and mTOR (Weichhart and Saemann, 2008;Weichhart and Saemann,
2009;Shimizu et al., 2012). Western blot analysis was used to measure the expression
levels of each protein. Figure 5A shows representative western blot bands for p-PI3K
and total PI3K. Densitometric analysis of the western blot bands showed significantly
increased expression of p-PI3K in the control and ACM+BMP-7 groups (Figure 5B).
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Figure 5: Activation of SMAD1/5/8 pathway results in activation of the p85 subunit of
PI3K. Representative western blot bands (A) are shown of p-PI3k and total PI3K.
Histogram (B) shows analysis of p-PI3K. *p<0.05 vs Control, #p<0.05 vs ACM, $p<0.05
vs ACM+BMP-7.
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Furthermore, Figure 6A and 6C show representative western blot bands for p-Akt
and p-PTEN with β-actin. Densitometric analysis of the p-Akt western blot bands show
a significant increase in expression of the ACM+BMP-7 group (Figure 6B). Figure 6D,
however, shows densitometric analysis of p-PTEN, an inhibitor of Akt, with a significant
decrease in the ACM+BMP-7 group and a significant increase in the ACM and
ACM+BMP-7+Foll groups. This suggests that PTEN is significantly inhibiting the PI3K
pathway. Figure 7A shows representative western blot bands of p-mTOR and total
mTOR. Densitometric analysis of the western blot bands show a significant increase in
the ACM+BMP-7 group (Figure 7B).
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Figure 6:
Activation of PI3K results in downstream phosphorylation of Akt.
Representative western blot bands (A) are shown of p-Akt and β-actin. Histogram (B)
shows analysis of p-Akt. Representative western blot bands (C) are shown of p-PTEN
and β-actin. Histogram (D) shows analysis of p-PTEN. *p<0.05 vs Control, #p<0.05 vs
ACM, $p<0.05 vs ACM+BMP-7.
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Figure 7: Downstream activation of mTOR occurs following phosphorylation of Akt.
Representative western blot bands (A) are shown of p-mTOR and total mTOR.
Histogram (B) shows densitometric analysis of the western blot bands for p-mTOR.
*p<0.05 vs Control, #p<0.05 vs ACM+BMP7.
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CHAPTER 4: DISCUSSION
Monocyte polarization is an important area of research that plays a significant
role in disease progression. During the onset of atherosclerosis, monocytes move to
the artery and polarize based on the stimuli they receive from the environment (Boon et
al., 2011;Moore and Tabas, 2011;Rocher et al., 2012).

In the early stages of

atherosclerosis, monocytes polarize to M2 macrophages, which secrete antiinflammatory cytokines to decrease the inflammatory response and prevent further
injury and also phagocytize the apoptotic cellular debris (Libby et al., 2009;Galkina and
Ley, 2009;Moore and Tabas, 2011). Unfortunately, as the atherosclerosis progresses
and the injury worsens, apoptosis increases and the cellular debris becomes necrotic
resulting in secretion of pro-inflammatory cytokines, which then induce the infiltrating
monocytes to polarize to an M1 macrophage cell type (Thorp and Tabas, 2009;Seimon
and Tabas, 2009). Being able to control the ratio of M1 to M2 macrophages could
inhibit the severity of the inflammatory response and allow for injury repair.
Studies have shown that monocytes are triggered to polarize based on the
stimuli they receive such as apoptotic cell death or increased cytokine levels (Voll et al.,
1997;Weigert et al., 2006;Rocher et al., 2012). In this study, we wanted to mimic the
inflammatory environment by adding apoptotic conditioned media (ACM) which has
been published by others and us (Xu et al., 2006;Weis et al., 2009;Rocher et al., 2012).
Adding this stressed condition induced the THP-1 cells to polarize from monocytes to
macrophages. To increase the polarization of monocytes to M2 macrophages BMP-7
was added to the THP-1. In this study when the THP-1 cells are treated with BMP-7
under stressed conditions for 48 hours, we see an increase in M2 macrophage markers
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suggesting that BMP-7 is successfully polarizing the THP-1 cells. We further confirmed
that BMPR2 is located on THP-1 cells through double label immunostaining with CD14,
a monocyte marker (Urbich et al., 2003;Rocher et al., 2012). In addition, we showed
that expression of BMPR2 is significantly increased following treatment with BMP-7
compared to control. We also showed that BMPR2 is found on M2 macrophages, which
was demonstrated through the double immunostaining performed on the THP-1 cells
following treatment, and was seen with the CD14 positive cells, expression was
significantly increased in the ACM+BMP-7 group compared to control.
Cell polarization was demonstrated through multiple methods, the first being
immunohistochemistry of the various monocyte and macrophage markers. Following
48-hour treatment of the THP-1 cells with BMP-7 under stressed conditions; the cell
smears were stained with anti-CD14, anti-CD206, anti-arginase-1 and anti-iNOS. The
CD14 marker confirmed that the THP-1 cells are monocytes and that following
treatment the percentage of CD14 positive cells decreased. Seeing that the percentage
decreased suggested that the cells are polarizing to another cell type.
CD206 and arginase-1, two markers of M2 macrophages, stainings were next
performed to see if indeed BMP-7 was successfully polarizing the cells to an M2
macrophage cell type (Sinha et al., 2005;El et al., 2012). As shown in the results
section, the percentage of cells expressing CD206 and arginase-1 was significantly
increased in the ACM+BMP-7 group and significantly decreased in the ACM and
ACM+BMP-7+Foll groups.

This suggests that THP-1 cells are polarizing into M2

macrophages do to treatment with BMP-7. Furthermore, the decrease of expression of
CD206 and arginase-1 in the follistatin group demonstrates that inhibition of BMP-7 is
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occurring and that since expression of M2 macrophage markers decreases when BMP7 is inhibited then BMP-7 must play an important role in the M2 macrophage
polarization. This is further shown by the iNOS immunostaining performed on the THP1 cells. A significant increase of iNOS expression was shown in the ACM and the
ACM+BMP-7+Foll groups but a significant decrease in the ACM+BMP-7 group showing
that BMP-7 treatment induces M2 macrophage polarization and not M1.
Cell polarization was further demonstrated through ELISA analysis of pro and
anti-inflammatory cytokine expression for each group.

Levels of pro-inflammatory

cytokines IL-6, TNF- α and MCP-1 and anti-inflammatory cytokines IL-10 and IL-1ra
were performed (Libby et al., 2009; Wolfs et al., 2011; El et al., 2012; Rocher et al.,
2012). The BMP-7 treated group was able to significantly lower levels of these proinflammatory cytokines compared to the ACM group but significantly increase levels of
IL-10 and IL-1ra. We show that following treatment with BMP-7, THP-1 cells polarize
into M2 macrophages. This data confirms studies done by others and us that BMP-7
can reduce levels of pro-inflammatory cytokines and be used as a treatment for
inflammatory diseases such as atherosclerosis (Rocher et al., 2012).
Understanding the mechanism for how BMP-7 polarizes THP-1 cells was
previously unknown. In this study, we show that BMP-7 works through two pathways.
The first pathway is SMAD1/5/8, a known mechanism for BMP-7 when binding occurs
through BMPR2 (Boon et al., 2011;Rocher et al., 2012). Western blot analysis confirms
that activation of the SMAD1/5/8 pathway occurs in the ACM+BMP-7 group.
Furthermore, it not only demonstrates that successful binding of BMP-7 occurs but also
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correlates with the data from Figure 1A regarding the location of the receptor on the cell
surface, since activation of the SMAD1/5/8 pathway occurs following binding of BMPR2.
In this study we also show that following binding of BMPR2 with BMP-7, the
PI3K-Akt-mTOR pathway is also activated. Studies have shown that this pathway is
very important to M2 macrophage polarization and its activation is seen as almost a
requirement for M2 macrophage polarization to occur (Martin et al., 2003;Rauh et al.,
2005;Weichhart and Saemann, 2008).

Inhibition of either PI3K or mTOR, by their

respective inhibitors results in polarization toward an M1 macrophage type with
increased pro-inflammatory cytokine expression (Martin et al., 2003; Rauh et al., 2005;
Weichhart and Saemann, 2009; Araki et al., 2011). Although studies have shown that
activation of this pathway can occur through BMPR2, no one has yet to show the
correlation of this activation with the polarization of M2 macrophages. In this study,
through western blot analysis, we show that expression of p-PI3K, p-Akt and p-mTOR is
significantly increased in the ACM+BMP-7 group. Conversely, western blot analysis of
p-PTEN shows that in the ACM and ACM+BMP-7+Foll groups, inhibition of the PI3K
pathway occurs which correlates with our previous data regarding cell polarization. The
groups that had increased expression of the PI3K pathway also had increased
expression of M2 macrophage markers whereas groups that had decreased expression
of PI3K had increased expression of M1 macrophage markers. This data suggests that
activation of the PI3K pathway is necessary for M2 macrophage polarization.
In conclusion, this study demonstrates that treatment with BMP-7 polarizes THP1 cells into M2 macrophages. We showed that THP-1 cells treated with BMP-7 had
increased expression of M2 macrophage markers as well as increased levels of anti-
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inflammatory cytokines.

Furthermore, our data suggests that polarization occurs

through activation of the PI3K-Akt-mTOR pathway following binding of BMPR2.
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